Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Cytovation logo — Creating transformative medicines for patients with cancer

Cytovation

Creating transformative medicines for patients with cancer

Founded 2015 Norway Norway 11 employees Series A Total: $285.00M Biotechnology, Life Sciences

General Information

Company Name Cytovation
Founded Year 2015
Location Norway Norway
Founders / Decision Makers
Team member
Employees 11
Industries Biotechnology, Life Sciences
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Cytovation. To contact Cytovation, visit cytovation.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cytovation compare?

A PDF of Cytovation and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cytovation soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cytovation

Cytovation ASA is a biotechnology startup based in Norway, with a vision to revolutionize cancer treatment. Its lead asset, CyPep-1, is a synthetic peptide designed to target tumor cells with a dual mechanism of action. This includes direct tumor-specific membrane lysis and in-situ vaccination, as well as immune activation through inhibition of the β-catenin pathway. Having showcased strong First in Human (FIH) clinical data, the company received a significant kr85.00M Series A investment on 2nd June 2023 from investors Canica and Project Sandwater. With this backing, Cytovation is focused on advancing CyPep-1 to Proof of Concept (POC) and pivotal clinical development, with a specific emphasis on β-catenin-driven cancers. Cytovation's commitment to creating transformative medicines for cancer patients positions it as an innovative and promising player in the immuno-oncology space.

Business keywords: immuno-oncology, biotech, clinical stage, immunotherapy, synthetic peptide, tumor-specific, solid tumors, in-situ vaccination, immune activation, β-catenin pathway, clinical development, cancer treatment, oncology, pharmaceuticals

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A kr85.00M 2
Canica
Canica, Project Sandwater
02 Jun 2023
Series A kr180.00M 2
Canica
Canica, Project Sandwater
25 Jan 2022
Venture Round kr20.00M -
29 Jun 2017

Cytovation Alternatives & Competitors

View All Alternatives
Cytovation vs
ImmunoGenesis, Inc.
ImmunoGenesis, Inc. United States

Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mechanisms of...

Venture round
14 employees
Biotechnology, Health Care
Cytovation vs
Memgen, Inc.
Memgen, Inc. United States

Memgen's Vision: Develop Life-Saving Cancer Immunotherapies

Venture round
7 employees
Biotechnology, Health Care
Cytovation vs
Epsilogen Ltd
Epsilogen Ltd United Kingdom

Harnessing the power of IgE

Series B
33 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Cytovation

Creating transformative medicines for patients with cancer
Cytovation was founded in 2015.
Cytovation is headquartered in Norway.
Cytovation operates in Biotechnology and Life Sciences. Its work centres on immuno-oncology, biotech, clinical stage and immunotherapy.
Cytovation has approximately 11 employees.
Cytovation has completed 3 funding rounds, raising a total of $285.00M. The latest funding stage is Series A.
Top alternatives and competitors to Cytovation include ImmunoGenesis, Inc., Memgen, Inc., Epsilogen Ltd, Carisma Therapeutics, Simcha Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cytovation and ImmunoGenesis, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cytovation, https://bouncewatch.com/company/cytovation-asa, updated 29 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout